Celgene's Bid To Trim Drug Monopoly Suit Denied
A suit accusing biopharmaceutical firm Celgene Corp. of locking two competing generic drugs out of the market remains intact in New Jersey federal court, after a judge has refused to toss...To view the full article, register now.
Already a subscriber? Click here to view full article